A Study of FCX-007 for Recessive Dystrophic Epidermolysis Bullosa (RDEB)
Status:
Recruiting
Trial end date:
0000-00-00
Target enrollment:
Participant gender:
Summary
The purpose of this study is to evaluate the safety of FCX-007, evaluate C7 expression and
the presence of anchoring fibrils resulting from FCX-007 and to analyze wound healing as a
result of FCX-007 administration in subjects with RDEB.